VAERS Explorer
Back to explore

Report #2881630

Received Jan 13, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
87 yrs
State
GA
Recovered
Not recovered
Vaccinated
Jan 8, 2026
Onset
Jan 9, 2026
Days to onset
1
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RSVRSV (AREXVY)GLAXOSMITHKLINE BIOLOGICALSUNKCM9A5—

Symptoms (1)

Pain in jaw

Symptom narrative

experienced jaw pain the day after he received the Arexvy vaccine; This non-serious case was reported by a consumer via call center representative and described the occurrence of jaw pain in a 87-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number CM9A5) for prophylaxis. On 08-JAN-2026, the patient received Arexvy. On 09-JAN-2026, 1 days after receiving Arexvy, the patient experienced jaw pain (Verbatim: experienced jaw pain the day after he received the Arexvy vaccine). The outcome of the jaw pain was not resolved. It was unknown if the reporter considered the jaw pain to be related to Arexvy. It was unknown if the company considered the jaw pain to be related to Arexvy.